Viewed in this context, our studies provide proof-of-concept that short-term NF-κB inhibition (after onset of sepsis but prior to development of lung injury) could be beneficial in preventing acute lung injury without negative effects on bacterial clearance or mortality. The gene discussed is NFKB1; the disease is Sepsis.